Your browser is no longer supported. Please, upgrade your browser.
Settings
ACHV Achieve Life Sciences, Inc. daily Stock Chart
ACHV [NASD]
Achieve Life Sciences, Inc.
Index- P/E- EPS (ttm)-2.38 Insider Own1.71% Shs Outstand20.42M Perf Week-5.35%
Market Cap10.15M Forward P/E- EPS next Y-1.15 Insider Trans0.00% Shs Float20.33M Perf Month-18.92%
Income-16.80M PEG- EPS next Q-0.33 Inst Own28.30% Short Float1.08% Perf Quarter-40.84%
Sales- P/S- EPS this Y83.60% Inst Trans129.70% Short Ratio0.09 Perf Half Y-73.28%
Book/sh1.01 P/B0.49 EPS next Y41.90% ROA-112.60% Target Price11.00 Perf Year-68.54%
Cash/sh0.36 P/C1.37 EPS next 5Y- ROE-147.60% 52W Range0.46 - 4.63 Perf YTD-6.21%
Dividend- P/FCF- EPS past 5Y56.70% ROI- 52W High-89.27% Beta1.58
Dividend %- Quick Ratio2.40 Sales past 5Y- Gross Margin- 52W Low7.11% ATR0.04
Employees13 Current Ratio2.40 Sales Q/Q- Oper. Margin- RSI (14)38.21 Volatility6.06% 6.79%
OptionableNo Debt/Eq0.05 EPS Q/Q36.50% Profit Margin- Rel Volume0.61 Prev Close0.51
ShortableYes LT Debt/Eq0.02 EarningsMar 12 BMO Payout- Avg Volume2.38M Price0.50
Recom1.50 SMA20-10.57% SMA50-16.48% SMA200-71.13% Volume1,460,125 Change-2.76%
Feb-06-20 08:00AM  Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users PR Newswire
Jan-13-20 06:30AM  Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery PR Newswire -7.80%
Dec-23-19 05:31AM  Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation Simply Wall St.
Dec-19-19 04:05PM  Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option CNW Group
Dec-17-19 01:06PM  Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering PR Newswire -36.49%
01:06PM  Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering CNW Group
Dec-09-19 05:30AM  Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program PR Newswire +14.27%
05:30AM  Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program CNW Group
Nov-11-19 10:00AM  ACHV: After Capital Raise Ready for Phase III Zacks Small Cap Research
Nov-06-19 06:30AM  Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program PR Newswire -13.93%
06:30AM  Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program CNW Group
Oct-31-19 05:30AM  Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019 CNW Group
Oct-24-19 07:11AM  What Type Of Shareholder Owns Achieve Life Sciences, Inc.'s (NASDAQ:ACHV)? Simply Wall St.
05:30AM  Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference PR Newswire
05:30AM  Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference CNW Group
Sep-30-19 05:30AM  Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study PR Newswire -9.57%
Sep-25-19 06:30AM  ACHV: Post Phase II Investor Day Zacks Small Cap Research
Sep-13-19 05:30AM  Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference PR Newswire
Sep-09-19 10:34AM  What Kind Of Share Price Volatility Should You Expect For Achieve Life Sciences, Inc. (NASDAQ:ACHV)? Simply Wall St.
Sep-05-19 05:30AM  Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial PR Newswire +5.71%
Sep-04-19 05:30AM  Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences PR Newswire +5.53%
Aug-26-19 02:30PM  ACHV: SRNT Presentation Next on Agenda Zacks Small Cap Research
10:30AM  ACHV: SRNT Presentation Next on Agenda Zacks Small Cap Research
Aug-08-19 05:39PM  /C O R R E C T I O N -- Achieve Life Sciences, Inc./ PR Newswire +5.71%
04:05PM  Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update CNW Group
Jul-30-19 05:30AM  Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 PR Newswire
05:30AM  Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 CNW Group
Jul-23-19 05:30AM  Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation PR Newswire
Jul-10-19 10:47AM  Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop? Simply Wall St.
Jun-21-19 10:38AM  Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference Benzinga
05:30AM  Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference PR Newswire
Jun-12-19 01:00PM  ACHV: ORCA-1 Topline Results and Comparison Zacks Small Cap Research -8.62%
Jun-11-19 07:00AM  Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial PR Newswire -25.26%
07:00AM  Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial CNW Group
Jun-03-19 04:05PM  Achieve Receives $4.2 Million from Exercise of Warrants PR Newswire
04:05PM  Achieve Receives $4.2 Million from Exercise of Warrants CNW Group
May-30-19 02:00PM  ACHV: 1Q:19 Financial & Operational Update Zacks Small Cap Research
05:30AM  Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline PR Newswire
May-15-19 04:05PM  Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update PR Newswire
04:05PM  Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update CNW Group
May-07-19 05:30AM  Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019 PR Newswire
Apr-26-19 10:00AM  ACHV: Final Enrollee, Final Visit Zacks Small Cap Research +8.21%
Apr-24-19 05:30AM  Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Apr-03-19 05:30AM  Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019 PR Newswire +5.64%
Apr-02-19 07:30AM  The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial Benzinga
05:30AM  Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Mar-25-19 10:00AM  ACHV: Fiscal Year 2018 Operational and Financial Results Zacks Small Cap Research +6.71%
Mar-18-19 08:35AM  What Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline ACCESSWIRE +5.32%
05:30AM  Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-15-19 04:05PM  Four Healthcare Stocks Picking Up Speed On Friday ACCESSWIRE +22.86%
Mar-14-19 04:05PM  Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update PR Newswire
Mar-12-19 01:00PM  ACHV: A Reason to Quit is a Reason to Buy Zacks Small Cap Research
Mar-05-19 05:30AM  Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019 PR Newswire
Feb-28-19 09:00AM  Predictive Technology Group Names Jay M. Moyes to Its Board of Directors GlobeNewswire
Feb-25-19 10:30AM  Healthcare Stocks Leading the Sector ACCESSWIRE -19.70%
06:26AM  Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful? Simply Wall St.
Feb-22-19 10:40AM  Four Healthcare Stocks Looking to Close Out a Strong Week ACCESSWIRE +84.36%
08:36AM  Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial MarketWatch
05:30AM  Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting PR Newswire
Feb-20-19 05:30AM  Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation PR Newswire -9.20%
Dec-28-18 07:06AM  5 Top Rising P/E Stocks to Enjoy Solid Gains Zacks
Dec-18-18 05:30AM  Achieve Announces Update on Cytisinicline Clinical Development Program PR Newswire -5.93%
Nov-29-18 08:06AM  Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals Zacks -6.63%
Nov-28-18 07:04AM  5 Top-Ranked Rising P/E Stocks to Lure Investors Zacks
Nov-07-18 04:05PM  Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update PR Newswire
Oct-31-18 05:30AM  Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018 PR Newswire
Oct-30-18 09:45AM  3 Healthcare Stocks that Could Move on Industry Growth ACCESSWIRE
05:30AM  Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation PR Newswire
Oct-03-18 12:41PM  Achieve Life Sciences Stock Will Probably Tumble Further InvestorPlace
Oct-01-18 09:05AM  Achieve Announces Pricing of $5.6 Million Registered Direct Offering PR Newswire -15.24%
Sep-27-18 08:56AM  Achieve Life Sciences' stock rockets on positive study results for smoking cessation drug MarketWatch +39.56%
05:30AM  Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects PR Newswire
Sep-26-18 05:30AM  Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018 PR Newswire
Sep-18-18 05:30AM  Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy PR Newswire
Sep-06-18 05:30AM  Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference PR Newswire
Sep-05-18 05:30AM  Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018 PR Newswire
Aug-08-18 04:05PM  Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update PR Newswire
Aug-02-18 05:30AM  Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018 PR Newswire
Jul-12-18 08:00AM  Today's Research Reports on Stocks to Watch: Achieve Life Sciences and Pfizer ACCESSWIRE -9.25%
Jul-11-18 10:52AM  Achieve Life Sciences Shares Surge On Development Plan For Smoking Cessation Candidate Benzinga +10.50%
05:30AM  Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA PR Newswire
Jun-27-18 08:00AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Achieve Life Sciences ACCESSWIRE -19.80%
Jun-26-18 11:41AM  Achieve Life Sciences Shares Rip Higher On Positive Data For Smoking Cessation Drug Benzinga +34.21%
05:30AM  Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction PR Newswire
Jun-19-18 04:01PM  Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option PR Newswire
Jun-15-18 08:30AM  Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering PR Newswire -29.81%
Jun-11-18 05:30AM  Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules PR Newswire
May-25-18 06:09PM  Should You Be Concerned About Achieve Life Sciences Incs (NASDAQ:ACHV) Shareholders? Simply Wall St.
May-23-18 05:30AM  Achieve Life Sciences, Inc. Announces Reverse Stock Split PR Newswire -9.91%
May-09-18 04:15PM  Achieve Reports Financial Results for First Quarter 2018 PR Newswire
May-07-18 05:30AM  Achieve Announces Patent Granted on Novel Formulation of Cytisine PR Newswire
Mar-06-18 05:30AM  Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health PR Newswire +7.94%
Mar-01-18 04:30PM  Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results PR Newswire
04:30PM  Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results CNW Group
Feb-20-18 05:30AM  Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study PR Newswire +6.34%
05:30AM  Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study CNW Group
Feb-13-18 07:00AM  Innovative Cancer Immunotherapy Company, Novelogics Biotechnology, Inc. adds Scott D. Cormack to the Board of Directors to Expand Strategic Growth Plans CNW Group
Feb-02-18 12:30PM  A Day Trader's View On Why Bigger Is (Usually) Better Benzinga
Jan-26-18 08:05AM  Achieve Life Sciences Making Progress in the Smoking Cessation Market, Recent Events ACCESSWIRE
Jan-24-18 05:30AM  Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories PR Newswire
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol; and a strategic collaboration with National Institutes of Health for the development of cytisinicline for smoking cessation. The company is based in Vancouver, Canada.